Arcadia Biosciences Inc. (RKDA) Insider Trading
No open-market buying or selling by insiders.
The last open-market buy by an executive or director was in Feb 2025.
Get an email when RKDA's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Mark Kawakami Chief Financial Officer | Bought | 700 | $2.49 | $2k | 35% | Form 4 |
| Feb 3, 2025 | Thomas J. Schaefer Chief Executive Officer | Bought | 700 | $2.49 | $2k | 33% | Form 4 |
- Feb 3, 2025Mark KawakamiChief Financial Officer · bought 700 at $2.49$2k35% of stake
- Feb 3, 2025Thomas J. SchaeferChief Executive Officer · bought 700 at $2.49$2k33% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Related stocks: Crude Petroleum & Natural Gas
Spot a number that looks wrong? Check it in RKDA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing RKDA
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.